Global Antibiotic Resistance Market Research Report 2023: The Changing Road to New Antibiotics & Technologies with 5 Year Forecasts
January 13, 2023 05:03 ET
|
Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Global Antimicrobial Resistance Diagnostics Market Report 2023: Increasing Incidences of Hospital-Acquired Infections Drives Demand
January 05, 2023 04:23 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals, Diagnostic...
Global Active Pharmaceutical Ingredient Global Market Report 2022: Growing Importance of Generics Bolsters Sector
December 28, 2022 06:58 ET
|
Research and Markets
Dublin, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product...
Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022
October 20, 2022 17:15 ET
|
Summit Therapeutics Inc.
Ridinilazole resulted in a 53% relative risk reduction in recurrence of C. difficile infection compared to treatment with vancomycin Ridinilazole preserved the gut microbiome compared to...
Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics' Clinical Advisory Board
October 17, 2022 10:01 ET
|
Selux Diagnostics
BOSTON, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that Dr....
Global Antimicrobial Resistance Diagnostic Markets 2022-2027: Diagnostic Technology Development Opportunities / The Key Large Market Opportunities in AMR
July 27, 2022 04:38 ET
|
Research and Markets
Dublin, July 27, 2022 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization" report has been...
Global Antibiotic Resistance Market Report 2022: New Technologies and New Drugs are Under Development to Capture this Growing Market
April 14, 2022 04:08 ET
|
Research and Markets
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Global Antimicrobial Resistance Diagnostic Market Report 2022-2027: Key Large Pathogen Opportunities in this Space and Developed Market Forecasts
January 24, 2022 04:38 ET
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization" report has been...
Global Antibiotics Markets Report 2021: Market was Valued at $46.66 Billion in 2020 - Forecast to 2026
January 04, 2022 07:08 ET
|
Research and Markets
Dublin, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Antibiotics Market - Analysis By Drug Class (Beta-Lactams, Cephalosporins, Lipopeptide, Others), Mechanism, By Region, By Country (2021...
Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021
September 30, 2021 09:00 ET
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying an important ePoster at IDWeek 2021. IDWeek is...